InsiderTrades.com logo

KYTX Insider Trading

Insider Ownership Percentage: 22.00%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $292,775.60

Kyverna Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Kyverna Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Kyverna Therapeutics Share Price & Price History

Current Price: $6.91
Price Change: ▼ Price Decrease of -3.33 (-32.52%)
As of 12/17/2025 05:00 PM ET

This chart shows the closing price history over time for KYTX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Kyverna Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/15/2025Karen Marie WalkerCTOSell23,998$12.20$292,775.6022,636View SEC Filing Icon  
2/12/2024Northpond Ventures Iii Gp, LlcMajor ShareholderBuy450,000$22.00$9,900,000.00450,000View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Kyverna Therapeutics (NASDAQ:KYTX)

18.08% of Kyverna Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at KYTX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Kyverna Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/17/2025Jacobs Levy Equity Management Inc.147,712$0.89M0.0%N/A0.337%Search for SEC Filing on Google Icon
11/17/2025Woodline Partners LP252,212$1.51M0.0%N/A0.576%Search for SEC Filing on Google Icon
11/17/2025Qube Research & Technologies Ltd36,691$0.22M0.0%+161.1%0.084%Search for SEC Filing on Google Icon
11/17/2025Prelude Capital Management LLC19,438$0.12M0.0%-46.4%0.044%Search for SEC Filing on Google Icon
11/17/2025Public Employees Retirement System of Ohio4,600$28K0.0%N/A0.011%Search for SEC Filing on Google Icon
11/17/2025Millennium Management LLC551,635$3.31M0.0%+21.9%1.259%Search for SEC Filing on Google Icon
11/17/2025Bank of America Corp DE64,964$0.39M0.0%+92.5%0.148%Search for SEC Filing on Google Icon
11/17/2025Ameriprise Financial Inc.12,882$77K0.0%N/A0.029%Search for SEC Filing on Google Icon
11/14/2025Two Sigma Investments LP132,451$0.80M0.0%+9.8%0.306%Search for SEC Filing on Google Icon
11/14/2025Bridgeway Capital Management LLC174,900$1.05M0.0%+178.1%0.404%Search for SEC Filing on Google Icon
11/13/2025UBS Group AG157,422$0.95M0.0%+60.4%0.364%Search for SEC Filing on Google Icon
11/13/2025BNP Paribas Financial Markets34,022$0.20M0.0%+667.8%0.079%Search for SEC Filing on Google Icon
11/13/2025Franklin Resources Inc.677,587$4.07M0.0%-2.5%1.567%Search for SEC Filing on Google Icon
11/13/2025Jefferies Financial Group Inc.16,300$98K0.0%N/A0.038%Search for SEC Filing on Google Icon
11/10/2025TD Asset Management Inc164,796$0.99M0.0%-34.7%0.381%Search for SEC Filing on Google Icon
11/10/2025Peapod Lane Capital LLC318,760$1.91M1.7%-19.7%0.737%Search for SEC Filing on Google Icon
11/7/2025Vanguard Group Inc.1,322,625$7.94M0.0%+0.8%3.058%Search for SEC Filing on Google Icon
11/7/2025JPMorgan Chase & Co.6,675$40K0.0%-76.0%0.015%Search for SEC Filing on Google Icon
11/3/2025Federated Hermes Inc.15,158$91K0.0%-65.6%0.035%Search for SEC Filing on Google Icon
10/21/2025Capital Advisors Inc. OK10,000$60K0.0%N/A0.023%Search for SEC Filing on Google Icon
10/17/2025Ethic Inc.15,353$92K0.0%-9.9%0.035%Search for SEC Filing on Google Icon
8/15/2025Bridgeway Capital Management LLC62,900$0.19M0.0%-53.9%0.145%Search for SEC Filing on Google Icon
8/15/2025Bank of America Corp DE33,756$0.10M0.0%+94.8%0.078%Search for SEC Filing on Google Icon
8/14/2025Jane Street Group LLC87,769$0.27M0.0%N/A0.203%Search for SEC Filing on Google Icon
8/14/2025The Manufacturers Life Insurance Company 118,297$0.36M0.0%+206.5%0.274%Search for SEC Filing on Google Icon
8/14/2025Qube Research & Technologies Ltd14,051$43K0.0%N/A0.033%Search for SEC Filing on Google Icon
8/14/2025Federated Hermes Inc.44,000$0.14M0.0%+22.2%0.102%Search for SEC Filing on Google Icon
8/13/2025Marshall Wace LLP62,057$0.19M0.0%+152.7%0.144%Search for SEC Filing on Google Icon
8/12/2025XTX Topco Ltd34,939$0.11M0.0%N/A0.081%Search for SEC Filing on Google Icon
8/12/2025JPMorgan Chase & Co.27,855$86K0.0%-29.5%0.064%Search for SEC Filing on Google Icon
8/12/2025Catalyst Funds Management Pty Ltd12,000$37K0.0%N/A0.028%Search for SEC Filing on Google Icon
8/8/2025Phoenix Wealth Advisors10,500$32K0.0%N/A0.024%Search for SEC Filing on Google Icon
8/8/2025Geode Capital Management LLC287,601$0.88M0.0%-49.0%0.665%Search for SEC Filing on Google Icon
8/1/2025Y Intercept Hong Kong Ltd42,025$0.13M0.0%N/A0.097%Search for SEC Filing on Google Icon
7/30/2025Ethic Inc.17,036$56K0.0%N/A0.039%Search for SEC Filing on Google Icon
7/28/2025TD Asset Management Inc252,196$0.77M0.0%+179.5%0.584%Search for SEC Filing on Google Icon
7/25/2025Vanguard Personalized Indexing Management LLC19,122$59K0.0%+25.2%0.044%Search for SEC Filing on Google Icon
7/1/2025Kera Capital Partners Inc.421,924$1.30M0.3%+12.2%0.976%Search for SEC Filing on Google Icon
6/27/2025Goldman Sachs Group Inc.104,460$0.20M0.0%-7.9%0.242%Search for SEC Filing on Google Icon
5/29/2025Rhumbline Advisers31,614$61K0.0%+22.0%0.073%Search for SEC Filing on Google Icon
5/16/2025Goldman Sachs Group Inc.104,460$0.20M0.0%-7.9%0.242%Search for SEC Filing on Google Icon
5/16/2025Insight Holdings Group LLC989,054$1.91M0.1%+8.3%2.288%Search for SEC Filing on Google Icon
5/16/2025AQR Capital Management LLC71,057$0.14M0.0%N/A0.164%Search for SEC Filing on Google Icon
5/15/2025Cubist Systematic Strategies LLC68,628$0.13M0.0%+31.1%0.159%Search for SEC Filing on Google Icon
5/14/2025Wellington Management Group LLP37,828$73K0.0%-86.2%0.088%Search for SEC Filing on Google Icon
5/12/2025Nuveen LLC47,508$92K0.0%N/A0.110%Search for SEC Filing on Google Icon
4/30/2025Peapod Lane Capital LLC396,221$0.77M0.9%N/A0.917%Search for SEC Filing on Google Icon
4/29/2025Bank of New York Mellon Corp48,784$94K0.0%+22.2%0.113%Search for SEC Filing on Google Icon
4/8/2025Rhumbline Advisers31,614$61K0.0%+22.0%0.073%Search for SEC Filing on Google Icon
3/24/2025Wellington Management Group LLP274,414$1.03M0.0%+16.7%0.636%Search for SEC Filing on Google Icon
2/19/2025Public Employees Retirement System of Ohio33,434$0.13M0.0%N/A0.077%Search for SEC Filing on Google Icon
2/17/2025Squarepoint Ops LLC11,488$43K0.0%N/A0.027%Search for SEC Filing on Google Icon
2/17/2025Two Sigma Advisers LP80,290$0.30M0.0%+375.1%0.186%Search for SEC Filing on Google Icon
2/17/2025Two Sigma Investments LP181,654$0.68M0.0%+47.9%0.421%Search for SEC Filing on Google Icon
2/17/2025Sphera Funds Management LTD.118,758$0.44M0.1%-52.2%0.275%Search for SEC Filing on Google Icon
2/17/2025Millennium Management LLC746,521$2.79M0.0%-40.4%1.729%Search for SEC Filing on Google Icon
2/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.14,288$53K0.0%+53.7%0.033%Search for SEC Filing on Google Icon
2/17/2025Integral Health Asset Management LLC350,000$1.31M0.1%+75.0%0.811%Search for SEC Filing on Google Icon
2/17/2025Jacobs Levy Equity Management Inc.461,959$1.73M0.0%+2,225.0%1.070%Search for SEC Filing on Google Icon
2/17/2025Corton Capital Inc.12,099$45K0.0%N/A0.028%Search for SEC Filing on Google Icon
2/17/2025Cubist Systematic Strategies LLC52,361$0.20M0.0%-24.1%0.121%Search for SEC Filing on Google Icon
2/17/2025Bridgeway Capital Management LLC80,000$0.30M0.0%N/A0.185%Search for SEC Filing on Google Icon
2/17/2025Bank of America Corp DE21,788$81K0.0%+41.6%0.050%Search for SEC Filing on Google Icon
2/17/2025BNP Paribas Financial Markets44,983$0.17M0.0%+65.4%0.104%Search for SEC Filing on Google Icon
2/17/2025Ameriprise Financial Inc.190,383$0.71M0.0%+55.1%0.441%Search for SEC Filing on Google Icon
2/14/2025Northern Trust Corp195,694$0.73M0.0%+46.1%0.453%Search for SEC Filing on Google Icon
2/14/2025Price T Rowe Associates Inc. MD593,688$2.22M0.0%-5.5%1.375%Search for SEC Filing on Google Icon
2/14/2025Stifel Financial Corp39,342$0.15M0.0%N/A0.091%Search for SEC Filing on Google Icon
2/14/2025Gilead Sciences Inc.4,126,119$15.43M1.0%N/A9.558%Search for SEC Filing on Google Icon
2/13/2025Marshall Wace LLP15,241$57K0.0%-52.7%0.035%Search for SEC Filing on Google Icon
2/13/2025XTX Topco Ltd43,949$0.16M0.0%-16.8%0.102%Search for SEC Filing on Google Icon
2/13/2025Barclays PLC89,586$0.34M0.0%+27.7%0.208%Search for SEC Filing on Google Icon
2/13/2025Renaissance Technologies LLC44,700$0.17M0.0%N/A0.104%Search for SEC Filing on Google Icon
2/13/2025Wells Fargo & Company MN179,012$0.67M0.0%+16.4%0.415%Search for SEC Filing on Google Icon
2/12/2025Geode Capital Management LLC539,682$2.02M0.0%+21.7%1.250%Search for SEC Filing on Google Icon
2/12/2025Franklin Resources Inc.692,028$2.59M0.0%-26.1%1.603%Search for SEC Filing on Google Icon
2/12/2025Wellington Management Group LLP274,414$1.03M0.0%+16.7%0.636%Search for SEC Filing on Google Icon
2/12/2025Norges Bank40,000$0.15M0.0%N/A0.093%Search for SEC Filing on Google Icon
2/12/2025JPMorgan Chase & Co.2,166,437$8.10M0.0%-9.3%5.018%Search for SEC Filing on Google Icon
2/11/2025Corebridge Financial Inc.12,811$48K0.0%+42.3%0.030%Search for SEC Filing on Google Icon
2/6/2025Charles Schwab Investment Management Inc.169,780$0.64M0.0%+1.9%0.393%Search for SEC Filing on Google Icon
2/4/2025Bank of New York Mellon Corp39,933$0.15M0.0%-7.7%0.093%Search for SEC Filing on Google Icon
1/30/2025Rhumbline Advisers25,920$97K0.0%+31.1%0.060%Search for SEC Filing on Google Icon
1/24/2025China Universal Asset Management Co. Ltd.9,154$34K0.0%N/A0.021%Search for SEC Filing on Google Icon
1/15/2025Kera Capital Partners Inc.376,131$1.41M0.4%N/A0.871%Search for SEC Filing on Google Icon
12/26/2024JPMorgan Chase & Co.2,387,352$11.67M0.0%+15.8%5.530%Search for SEC Filing on Google Icon
11/27/2024Franklin Resources Inc.936,961$4.58M0.0%+13.8%2.170%Search for SEC Filing on Google Icon
11/19/2024Barclays PLC70,167$0.34M0.0%+21.5%0.163%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC443,312$2.17M0.0%+19.0%1.027%Search for SEC Filing on Google Icon
11/15/2024Barclays PLC70,167$0.34M0.0%+21.5%0.163%Search for SEC Filing on Google Icon
11/15/2024XTX Topco Ltd52,792$0.26M0.0%-36.6%0.122%Search for SEC Filing on Google Icon
11/15/2024Jane Street Group LLC39,193$0.19M0.0%+78.3%0.091%Search for SEC Filing on Google Icon
11/15/2024Wellington Management Group LLP235,123$1.15M0.0%-67.0%0.545%Search for SEC Filing on Google Icon
11/15/2024Sphera Funds Management LTD.248,651$1.22M0.2%+5.3%0.576%Search for SEC Filing on Google Icon
11/15/2024State Street Corp326,192$1.60M0.0%+3.2%0.756%Search for SEC Filing on Google Icon
11/15/2024Point72 Asset Management L.P.34,482$0.17M0.0%N/A0.080%Search for SEC Filing on Google Icon
11/15/2024Jacobs Levy Equity Management Inc.19,869$97K0.0%N/A0.046%Search for SEC Filing on Google Icon
11/14/2024Verition Fund Management LLC44,626$0.22M0.0%N/A0.103%Search for SEC Filing on Google Icon
11/14/2024UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC101,900$0.50M0.0%-11.7%0.236%Search for SEC Filing on Google Icon
11/13/2024BNP Paribas Financial Markets27,197$0.13M0.0%+2,166.4%0.063%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Kyverna Therapeutics logo
Kyverna Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing cell therapies for patients suffering from autoimmune diseases. Its lead product candidate is KYV-101, an autologous CD19 CAR T-cell product candidate for the treatment of patients with lupus nephritis and systemic sclerosis that is in Phase I clinical trial; and for myasthenia gravis and multiple sclerosis that is in Phase II clinical trial. The company is also developing KYV-201, an allogeneic CD19 CAR T-cell product candidate that is in preclinical stage to treat multiple autoimmune diseases. In addition, it is developing product candidates to treat other autoimmune diseases, such as inflammatory bowel disease that includes Crohn's disease and ulcerative colitis. Kyverna Therapeutics, Inc. has a license and collaboration agreement with Intellia Therapeutics, Inc. to research and develop an allogeneic CD19-directed CAR cell therapy product; and with Kite to research and develop programs for the treatment, diagnosis, and prevention of autoimmune, inflammatory, and allogeneic stem cell transplant inflammatory diseases. The company was formerly known as BAIT Therapeutics, Inc. and changed its name to Kyverna Therapeutics, Inc. in October 2019. Kyverna Therapeutics, Inc. was incorporated in 2018 and is headquartered in Emeryville, California.
Read More on Kyverna Therapeutics

Today's Range

Now: $6.91
Low: $6.72
High: $7.41

50 Day Range

MA: $7.38
Low: $6.36
High: $10.82

52 Week Range

Now: $6.91
Low: $1.78
High: $13.67

Volume

15,556,359 shs

Average Volume

1,474,894 shs

Market Capitalization

$302.66 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

3.66

Who are the company insiders with the largest holdings of Kyverna Therapeutics?

Kyverna Therapeutics' top insider investors include:
  1. Northpond Ventures Iii Gp, Llc (Major Shareholder)
  2. Karen Marie Walker (CTO)
Learn More about top insider investors at Kyverna Therapeutics.

Who are the major institutional investors of Kyverna Therapeutics?

Kyverna Therapeutics' top institutional investors include:
  1. Vanguard Group Inc. — 3.06%
  2. Franklin Resources Inc. — 1.57%
  3. Millennium Management LLC — 1.26%
  4. Peapod Lane Capital LLC — 0.74%
  5. Woodline Partners LP — 0.58%
  6. Bridgeway Capital Management LLC — 0.40%
Learn More about top institutional investors of Kyverna Therapeutics stock.

Which institutional investors are selling Kyverna Therapeutics stock?

Within the previous quarter, KYTX stock was sold by these institutional investors:
  1. TD Asset Management Inc
  2. Peapod Lane Capital LLC
  3. Federated Hermes Inc.
  4. JPMorgan Chase & Co.
  5. Franklin Resources Inc.
  6. Prelude Capital Management LLC
  7. Ethic Inc.

Which institutional investors are buying Kyverna Therapeutics stock?

Within the previous quarter, KYTX stock was bought by institutional investors including:
  1. Woodline Partners LP
  2. Jacobs Levy Equity Management Inc.
  3. Bridgeway Capital Management LLC
  4. Millennium Management LLC
  5. UBS Group AG
  6. Bank of America Corp DE
  7. BNP Paribas Financial Markets
  8. Qube Research & Technologies Ltd